American Century Companies’s Amedisys AMED Stock Holding History

American Century Companies's AMED Position: Q1 2023 in Review

American Century Companies sold out of Amedisys (AMED) in Q1 2023, closing a stake of 88,747 shares — an estimated $7.41M sold.

American Century Companies first reported a position in AMED in Q2 2014 and held it in 27 quarters. The position peaked at $113M in Q4 2020. 281 funds tracked by Wall St. Rank hold AMED as of Q1 2023.

• American Century Companies reported no remaining Amedisys position as of Q1 2023 after selling out during the quarter.
• American Century Companies sold 88,747 Amedisys shares in Q1 2023, an estimated $7.41M.
• American Century Companies first reported a position in Amedisys in Q2 2014 and held it in 27 quarters.
• American Century Companies's Amedisys position peaked at $113M in Q4 2020.
• 281 funds tracked by Wall St. Rank held Amedisys as of Q1 2023.

Based on American Century Companies's 13F filing for Q1 2023, filed 11 May 2023.